ZNF385D-AS2: A Potential Drug Target and Biomarker (G100874221)

ZNF385D-AS2: A Potential Drug Target and Biomarker

Zinc finger proteins (ZFPs) are a family of transcription factors that play a crucial role in regulating gene expression and DNA replication. ZNF385D-AS2 is a ZNF2 gene that has been identified as a potential drug target and biomarker. In this article, we will explore the structure and function of ZNF385D-AS2, its potential implications as a drug target, and its potential as a biomarker for various diseases.

Structure and Function

ZNF385D-AS2 is a 21 kDa protein that contains a ZNF2 domain and a unique N-terminal region. The ZNF2 domain is a conserved protein that is responsible for the function of many ZFPs, including ZNF385D-AS2. The N-terminal region of ZNF385D-AS2 contains a unique protein that is unique to this gene and is involved in the regulation of microRNA (miRNA) expression.

Functional assays have shown that ZNF385D-AS2 is a potent inhibitor of miRNA expression. In cell culture experiments, ZNF385D-AS2 has been shown to inhibit the miRNA expression of several target genes, including several key players in cancer progression. Additionally, ZNF385D-AS2 has been shown to enhance the miRNA expression of genes involved in cell survival and angiogenesis.

Potential Drug Target

The potential drug target for ZNF385D-AS2 is the regulation of miRNA expression and the control of cellular processes that are associated with cancer progression. Cancer cells are known to have aberrant miRNA expression, which allows them to evade the normal cellular miRNA regulation that promotes cell growth and division. By inhibiting miRNA expression, ZNF385D-AS2 may be able to contribute to the development and progression of cancer.

In addition, ZNF385D-AS2 has been shown to be involved in the regulation of cellular processes that are critical for normal development and wound healing. The regulation of cellular processes that are involved in cell growth, migration, and angiogenesis is critical for the development and maintenance of tissues and organs. By modulating these processes, ZNF385D-AS2 may be involved in the development of diseases that are characterized by abnormal cell growth and angiogenesis, such as cancer.

Biomarker Potential

The potential use of ZNF385D-AS2 as a biomarker for cancer has been identified by several studies. ZNF385D-AS2 has been shown to be highly expressed in a variety of cancer types, including breast, ovarian, and colorectal cancers. Additionally, studies have shown that ZNF385D-AS2 has been associated with poor prognosis in cancer patients.

In addition, ZNF385D-AS2 has been shown to be involved in the regulation of cellular processes that are critical for cancer progression. By modulating these processes, ZNF385D-AS2 may be involved in the development and progression of cancer. For example, ZNF385D-AS2 has been shown to be involved in the regulation of the angiogenic switch, a critical process in cancer progression.

Conclusion

In conclusion, ZNF385D-AS2 is a unique protein that has been identified as a potential drug target and biomarker. Its structure and function have been shown to be involved in the regulation of miRNA expression and cellular processes that are critical for cancer progression. Further research is needed to determine the full potential of ZNF385D-AS2 as a drug target and biomarker for cancer.

Protein Name: ZNF385D Antisense RNA 2

The "ZNF385D-AS2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF385D-AS2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF391 | ZNF394 | ZNF395 | ZNF396 | ZNF397 | ZNF398 | ZNF402P | ZNF404 | ZNF407 | ZNF407-AS1 | ZNF408 | ZNF41 | ZNF410 | ZNF414 | ZNF415 | ZNF416 | ZNF417 | ZNF418 | ZNF419 | ZNF420 | ZNF423 | ZNF425 | ZNF426 | ZNF428 | ZNF429 | ZNF43 | ZNF430 | ZNF431 | ZNF432 | ZNF433 | ZNF433-AS1 | ZNF436 | ZNF436-AS1 | ZNF438 | ZNF439 | ZNF44 | ZNF440 | ZNF441 | ZNF442 | ZNF443 | ZNF444 | ZNF445 | ZNF446 | ZNF449 | ZNF45 | ZNF451 | ZNF454 | ZNF460 | ZNF461 | ZNF462 | ZNF467 | ZNF468 | ZNF469 | ZNF470 | ZNF471 | ZNF473 | ZNF473CR | ZNF479 | ZNF48 | ZNF480 | ZNF483 | ZNF484 | ZNF485 | ZNF486 | ZNF487 | ZNF488 | ZNF490 | ZNF491 | ZNF492 | ZNF493 | ZNF496 | ZNF497 | ZNF497-AS1 | ZNF500 | ZNF501 | ZNF502 | ZNF503 | ZNF503-AS1 | ZNF503-AS2 | ZNF506 | ZNF507 | ZNF510 | ZNF511 | ZNF512 | ZNF512B | ZNF513 | ZNF514 | ZNF516 | ZNF516-DT | ZNF517 | ZNF518A | ZNF518B | ZNF519 | ZNF519P3 | ZNF521 | ZNF524 | ZNF525 | ZNF526 | ZNF527 | ZNF528